Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.
News about MJN
Buy Netflix (NFLX) Stock On the Dip Before Q3 Earnings?
Netflix (NFLX ) stock has suffered since its now infamous Q2 subscriber miss. But the streaming TV giant’s growth prospects look strong as it continues to bulk up on content, which includes a new movie starring global superstar Dwayne “T...Read More>>>
Is Medical Marijuana Inc. a Buy?
Medical Marijuana (NASDAQOTH:MJNA) is only a matter of months away from its 10-year anniversary as the first publicly traded cannabis stock. Despite its elder-statesman status, however, Medical Marijuana hasn't been kind to investors since going publ...Read More>>>
Marijuana Use Is Suddenly "Booming" With This Group of People
The green rush is officially on. In 32 days, Canada will lift the curtain and allow recreational marijuana to be legally sold in licensed dispensaries. Although Uruguay became the first country in the world to legalize adult-use pot, Canada is set to...Read More>>>
Scotts Miracle Gro: The Best Indirect Marijuana Play
There are many ways to invest in the potential marijuana boom. Many are plays for recreational marijuana which will boom if legalization goes as expected. Many are medical plays which are incredibly likely to be successful but the upside is smaller. ...Read More>>>
Microsoft: Low Downside Risk, But Potential For Innovation-Driven Upside With Cloud And GitHub
Even as Microsoft's (MSFT) stock has been flat or down this month since the GitHub acquisition, I believe in the long-term GitHub has significant chances in boosting a variety of Microsoft software and Internet services segments, even outside of clou...Read More>>>